Predicting Food Effects on Drug Release from Extended-Release Oral Dosage Forms Containing a Narrow Therapeutic Index Drug

被引:17
|
作者
Klein, Sandra [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-60438 Frankfurt, Germany
来源
DISSOLUTION TECHNOLOGIES | 2009年 / 16卷 / 03期
关键词
IN-VIVO DISSOLUTION; GASTROINTESTINAL TRANSIT; THEOPHYLLINE ABSORPTION; FORMULATION; VITRO; BIOAVAILABILITY; DELIVERY; MATRICES; SINGLE; TRACT;
D O I
10.14227/DT160309P28
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two schemes were designed to facilitate easy and efficient preparation of biorelevant "pH gradients" representing small intestinal conditions in the fasted and fed states. Results of release tests performed on theophylline MR preparations using these profiles correlated well with in vivo data (3). This indicates that the new schemes can be very useful in terms of performing effective and reliable in vitro tests to predict the in vivo behavior of MR dosage forms.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 50 条
  • [21] METHODS OF FOLLOWING DRUG RELEASE FROM CONTROLLED RELEASE DOSAGE FORMS
    GOULD, PL
    BRITISH POLYMER JOURNAL, 1983, 15 (04): : 172 - 176
  • [22] Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir
    Michael W. Jann
    Vicky Spratlin
    Kathryn Momary
    Hailing Zhang
    David Turner
    Scott R. Penzak
    Alan Wright
    Chad VanDenBerg
    European Journal of Clinical Pharmacology, 2012, 68 : 715 - 721
  • [23] Physiological Considerations and In Vitro Strategies for Evaluating the Influence of Food on Drug Release from Extended-Release Formulations
    Mirko Koziolek
    Edmund Kostewicz
    Maria Vertzoni
    AAPS PharmSciTech, 2018, 19 : 2885 - 2897
  • [24] Physiological Considerations and In Vitro Strategies for Evaluating the Influence of Food on Drug Release from Extended-Release Formulations
    Koziolek, Mirko
    Kostewicz, Edmund
    Vertzoni, Maria
    AAPS PHARMSCITECH, 2018, 19 (07): : 2885 - 2897
  • [25] Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir
    Jann, Michael W.
    Spratlin, Vicky
    Momary, Kathryn
    Zhang, Hailing
    Turner, David
    Penzak, Scott R.
    Wright, Alan
    VanDenBerg, Chad
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 715 - 721
  • [26] Effects of food on the absorption of lovastatin following administration from an extended-release dosage fork
    Lamson, M
    Niecestro, R
    Walters, E
    Lukacsko, P
    Friedhoff, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1063 - 1063
  • [27] Release mechanisms and applications of drug delivery systems for extended-release
    Wang, Shuying
    Liu, Renhe
    Fu, Yao
    Kao, W. John
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (09) : 1289 - 1304
  • [28] Process of drug release with oral dosage forms with a lipidic gelucire matrix
    Ainaoui, A
    Ouriemchi, EM
    Bidah, D
    ElAmrani, MK
    Vergnaud, JM
    JOURNAL OF POLYMER ENGINEERING, 1997, 17 (03) : 245 - 255
  • [29] Tunable Drug Release Rate Using Modular Oral Dosage Forms
    Cano-Vega, Mario A.
    Arango-Salazar, Laura M.
    Pinal, Rodolfo
    PHARMACEUTICS, 2023, 15 (07)
  • [30] EVALUATION OF DIFFERENT METRICS AS INDIRECT MEASURES OF RATE OF DRUG ABSORPTION FROM EXTENDED-RELEASE DOSAGE FORMS AT STEADY-STATE
    REPPAS, C
    LACEY, LF
    KEENE, ON
    MACHERAS, P
    BYE, A
    PHARMACEUTICAL RESEARCH, 1995, 12 (01) : 103 - 107